Reversible, Non-Barrier Male Contraception: Status and Prospects

Slides:

Advertisements

Similar presentations

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.

Advertisements

The PSA Era is not Over for Prostate Cancer

B. Major regulatory effects of ovarian steroids on hypothalamic-pituitary function. Estrogen decreases the amount of follicle-stimulating hormone (FSH)

Copyright © 2015 by the American Osteopathic Association.

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Female Urinary Incontinence in the West of Turkey: Prevalence, Risk Factors and Impact on Quality of Life Izzet Kocak, Pinar Okyay, Mehmet Dundar, Haluk.

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Gender Equality from a European Perspective: Myth and Reality

Volume 62, Issue 6, Pages (December 2012)

Volume 72, Issue 5, Pages (November 2017)

Volume 54, Issue 4, Pages (October 2008)

Validity and Reliability of a Questionnaire for Evaluating Nocturia, Nocturnal Enuresis and Sleep-Interruptions in an Elderly Population M.H. Bing, L.A.

Association between Smoking, Passive Smoking, and Erectile Dysfunction: Results from the Boston Area Community Health (BACH) Survey Varant Kupelian,

Volume 50, Issue 5, Pages (November 2006)

Let the Games Begin (with EAU Approval)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

FSH versus estrogen: Who's guilty of breaking bones?

Failure to Achieve Castration Levels in Patients Using Leuprolide Acetate in Locally Advanced Prostate Cancer Olav Erich Yri, Trine Bjoro, Sophie D.

John P. Mulhall, Francesco Montorsi European Urology

Volume 53, Issue 2, Pages (February 2008)

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

Pseudocyesis The Journal for Nurse Practitioners

Can Pregnancy Stop Cyclical Attacks of Porphyria?

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Male contraception Fertility and Sterility

Volume 47, Issue 2, Pages (February 2005)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Sexual Dysfunction and Lower Urinary Tract Symptoms (LUTS) Associated with Benign Prostatic Hyperplasia (BPH) Raymond C. Rosen, Francois Giuliano, Culley.

Volume 51, Issue 1, Pages (January 2007)

Michele A. Hanson, M.D., Daniel A. Dumesic, M.D.

P.M.J. Moonen, L.A.L.M. Kiemeney, J.A. Witjes European Urology

Volume 48, Issue 4, Pages (October 2005)

Volume 70, Issue 1, Pages (July 2016)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Volume 47, Issue 5, Pages (May 2005)

Volume 65, Issue 4, Pages (April 2014)

Prostate Cancer Epidemic in Sight?

James N. Armitage, Stuart O. Irving, Neil A. Burgess European Urology

Volume 48, Issue 4, Pages (October 2005)

The PSA Era is not Over for Prostate Cancer

Global Burden of Urologic Cancers, 1990–2013

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Relationship between Lower Urinary Tract Symptoms Frequency Assessed by the IPSS and Bothersomeness (SPI) among Men Older than 50 Years Old P. Perrin,

Trends in Hypospadias Surgery: Results of a Worldwide Survey

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Treatment of Bacterial Urinary Tract Infections: Presence and Future

The Inside-Out Transobturator Male Sling for the Surgical Treatment of Stress Urinary Incontinence After Radical Prostatectomy: Midterm Results of a Single-Center.

Skeletal Morbidity in Men with Prostate Cancer: Quality-of-Life Considerations throughout the Continuum of Care Fred Saad, Carl Olsson, Claude C. Schulman

Volume 50, Issue 5, Pages (November 2006)

Volume 46, Issue 5, Pages (November 2004)

Volume 55, Issue 3, Pages (March 2009)

FSH versus estrogen: Who's guilty of breaking bones?

Volume 74, Issue 5, Pages (November 2018)

Testicular Cancer Variations in Time and Space in Europe

Volume 72, Issue 5, Pages (November 2017)

Chao-Chin Hsu, M. D. , Ph. D. , Hsin-Chih Kuo, Ph. D

Caring for adolescent renal patients

European Urology is “Your” Journal

Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.

The Burden of Stress Urinary Incontinence

Does Testosterone Have a Role in Erectile Function?

Bertrand Tombal, Richard Berges

Diagnosis and Management of Cryptorchidism

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Volume 51, Issue 5, Pages (May 2007)

Fig. 1. Image explaining the contraceptive effect of exogenous testosterone. In summary, it works by 2 mechanisms, decreasing intra-testicular testosterone,

Appropriate Castration with Luteinising Hormone Releasing Hormone (LHRH) Agonists: What is the Optimal Level of Testosterone? B. Tombal European Urology.

Presentation transcript:

Reversible, Non-Barrier Male Contraception: Status and Prospects C.E. Hoesl, F. Saad, M. Pöppel, J.E. Altwein European Urology Volume 48, Issue 5, Pages 712-723 (November 2005) DOI: 10.1016/j.eururo.2005.03.010 Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 1 Contraceptive use in more versus less developed countries [2]. European Urology 2005 48, 712-723DOI: (10.1016/j.eururo.2005.03.010) Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 2 Acceptability of a male oral pharmacological contraceptive (participants of the survey were men) [3]. European Urology 2005 48, 712-723DOI: (10.1016/j.eururo.2005.03.010) Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 3 Acceptability of a male hormonal contraceptive (participants of the survey were women) [4]. European Urology 2005 48, 712-723DOI: (10.1016/j.eururo.2005.03.010) Copyright © 2005 Elsevier B.V. Terms and Conditions

Fig. 4 Hormonal regulation of testicular function and spermatogenesis: GnRH – gonadotropin releasing hormone, LH – luteinizing hormone, FSH – follicle stimulating hormone. European Urology 2005 48, 712-723DOI: (10.1016/j.eururo.2005.03.010) Copyright © 2005 Elsevier B.V. Terms and Conditions